Physician profile
Anthony D Mercando
NPI 1528070505
$16,559.40
in general payments reported to CMS, 2019-2025
27 companies · $3,383 in 2025
The $3,383 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,112 · 2020: $1,045 · 2021: $748 · 2022: $1,104 · 2023: $1,308 · 2024: $2,858 · 2025: $3,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,327 · Consulting Fee: $1,163 · Travel and Lodging: $59.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,327.45 |
| Consulting Fee | $1,162.50 |
| Travel and Lodging | $59.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,893.17 | 2019-2025 | |
| Boston Scientific Corporation | $3,056.29 | 2019-2025 | Watchman Flx, Watchman Access System, Latitude Communicator Power Supply |
| E.R. Squibb & Sons, L.L.C. | $1,690.81 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $1,446.56 | 2019-2025 | Jot Dx, Aveir, Cardiomems |
| Astrazeneca Uk Limited | $1,162.50 | 2025 | Wainua |
| Merck Sharp & Dohme LLC | $1,089.67 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $902.79 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $814.31 | 2019-2025 | Farxiga, Brilinta |
| Novartis Pharmaceuticals Corporation | $361.41 | 2023-2025 | |
| Bridgebio Pharma, INC. | $312.01 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.02 | 2022-2025 | Lifevest |
| Biotronik INC. | $283.97 | 2019-2024 | Acticor 7 Vr-T Dx |
| Medtronic, INC. | $174.26 | 2024-2025 | Mycarelink, Linq II |
| Irhythm Technologies, INC. | $166.72 | 2023 | Zio Xt Patch |
| Celgene Corporation | $150.71 | 2023-2025 | Camzyos |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $148.14 | 2025 | |
| Janssen Pharmaceuticals, INC | $124.98 | 2021 | |
| Medtronic Vascular, INC. | $120.43 | 2019 | |
| Inspire Medical Systems, INC. | $111.51 | 2024 | Inspire |
| Philips North America LLC | $59.75 | 2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Edwards Lifesciences Corporation | $40.72 | 2024 | Pascal |
| Kerecis Limited | $37.60 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Imperative Care, INC | $31.79 | 2025 | Prodigy Catheter |
| Lilly USA, LLC | $26.58 | 2025 | Mounjaro, Zepbound |
| Shockwave Medical, INC | $22.16 | 2025 | |
| Stryker Corporation | $20.92 | 2025 | Limflow System |
| Sirtex Medical INC | $19.62 | 2025 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mercando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.